CLEVER HANDELN

Richten Sie Börsennews.de als Startseite ein

Hier klicken

CELSION Aktie

CELSION CORP. REGISTERED SHARES NEW DL -,01

ISIN: US15117N3052

 | 

WKN: A0JEGG

 | 

Symbol: CBOA

 | 

Land: USA


1,50 EUR -4,4089%

Die besten Rohstoffaktien der Welt

Zu Ihrem Onlinebroker

kaufen verkaufen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen

CELSION Aktienkurs

: 25.05. ( 15 Min. verzögert)
1,50 €
Letzter Kurs
 -4,41%
Veränderung
 1,57 €
Vortag
 1,50 €
Eröffnungskurs

Alle News aus dem Web zur CELSION Aktie

  • 25.05.

    Roth Capital Starts Stock Coverage on Celsion (CLSN)

    Investment analysts at Roth Capital assumed coverage on shares of Celsion (NASDAQ: CLSN) in a note issued to investors on Thursday. The firm set a “buy” rating on the stock. Shares...

  • 23.05.

    Insiders Persistent At Celsion

    Shares of Celsion (CLSN) continue to mark time as the company gets closer to the binary outcome of a key drug approval or...

  • 18.05.

    M&A Activity and a Growing Rate of FDA Approvals Contributing Factors to ...

    The Paragon Report examines investing opportunities in the Biotech Industry and provides equity research on AEterna Zentaris Inc. (NASDAQ:AEZS) and Celsion Corporation (NASDAQ:CLSN) . "In 2011, the US FDA approved 30 new drugs, compared to 21 in 2010.

  • 15.05.

    Celsion Q1 Loss Widens

    (RTTNews) - Celsion Corp. (CLSN: News ) reported a first-quarter net loss of $6.2 million, or $0.19 per share, compared to a net...

  • 15.05.

    Celsion Reports First Quarter 2012 Financial Results

    LAWRENCEVILLE, NJ, May 15, 2012 (MARKETWIRE via COMTEX) -- Celsion Corporation (NASDAQ:CLSN) , a leading oncology drug development company, today announced financial results for the first quarter ended March 31,...